Violet Slettenaar

Title: The Innovative Contributions of Violet Slettenaar

Introduction

Violet Slettenaar is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly in the identification and treatment of cancer markers. With a total of 2 patents, her work has the potential to impact cancer diagnostics and therapeutics.

Latest Patents

Violet's latest patents focus on the chemokine receptor CCR4 and its ligands CCL17 and CCL22. These markers are crucial for the identification and staging of cancer. Research indicates that the levels of CCR4, CCL17, and CCL22 increase during malignant tumor progression. This discovery allows for the stratification of cancer patients based on their suitability for treatment with anti-cancer agents. Additionally, her patents provide methods for measuring the levels of these markers in patient samples, offering diagnostic information. Furthermore, her work includes methods of treatment for cancer patients using agents that modulate the activity of CCR4, CCL17, and CCL22.

Career Highlights

Violet Slettenaar is associated with Cancer Research Technology Limited, where she continues to advance her research. Her innovative work has positioned her as a key figure in the field of cancer diagnostics and treatment.

Collaborations

Some of her notable coworkers include Frances Rosemary Balkwill and Julia Wilson. Their collaborative efforts contribute to the ongoing research and development in cancer therapeutics.

Conclusion

Violet Slettenaar's contributions to cancer research through her patents and collaborations highlight her role as an influential inventor in the field. Her work not only enhances our understanding of cancer markers but also paves the way for improved treatment options for patients.